Home › Heart Diseases › Virginia › Arlington
Heart Diseases clinical trials in Arlington, VA
4 studies for Heart Diseases are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ELEVATE-HFpEF Clinical Study
Recruiting
- Inova Fairfax Hospital, Falls Church · 4 mi away
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Inova Fairfax Hospital, Fairfax · 11 mi away
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Recruiting
- Inova Fairfax Medical Campus, Falls Church · 4 mi away
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- INOVA Fairfax Hospital, Falls Church · 4 mi away
About Heart Diseases
Heart disease is the leading cause of death in the U.S. Learn about the different types of heart diseases, and what you can do to try to prevent them.
More about Heart Diseases on MedlinePlus
Heart Diseases trials in other cities
- New York City, NY18 studies
- Boston, MA14 studies
- Cleveland, OH13 studies
- Los Angeles, CA12 studies
- Portland, OR11 studies
- Philadelphia, PA11 studies
- Atlanta, GA10 studies
- Rochester, MN10 studies
- Dallas, TX10 studies
- Durham, NC10 studies
- Washington, DC9 studies
- Baltimore, MD9 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Breast Cancer46 studies
- Ovarian Cancer46 studies
- Lung Cancer41 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.